These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Prognostic value of aortic root calcification volume on clinical outcomes after transcatheter balloon-expandable aortic valve implantation. Watanabe Y; Lefèvre T; Bouvier E; Arai T; Hayashida K; Chevalier B; Romano M; Hovasse T; Garot P; Donzeau-Gouge P; Farge A; Cormier B; Morice MC Catheter Cardiovasc Interv; 2015 Nov; 86(6):1105-13. PubMed ID: 25945689 [TBL] [Abstract][Full Text] [Related]
15. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G; JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026 [TBL] [Abstract][Full Text] [Related]
16. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Nombela-Franco L; Ruel M; Radhakrishnan S; Webb JG; Hansen M; Labinaz M; Thompson C; Fremes S; Dumont E; DeLarochellière R; Doyle D; Urena M; Mok M; Ribeiro HB; Roifman I; Watkins S; Dumesnil JG; Pibarot P; Rodés-Cabau J Am J Cardiol; 2013 Apr; 111(7):1026-33. PubMed ID: 23351465 [TBL] [Abstract][Full Text] [Related]
17. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK; JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819 [TBL] [Abstract][Full Text] [Related]
18. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. Hansson NC; Nørgaard BL; Barbanti M; Nielsen NE; Yang TH; Tamburino C; Dvir D; Jilaihawi H; Blanke P; Makkar RR; Latib A; Colombo A; Tarantini G; Raju R; Wood D; Andersen HR; Ribeiro HB; Kapadia S; Min J; Feuchtner G; Gurvitch R; Alqoofi F; Pelletier M; Ussia GP; Napodano M; Sandoli de Brito F; Kodali S; Pache G; Canovas SJ; Berger A; Murphy D; Svensson LG; Rodés-Cabau J; Leon MB; Webb JG; Leipsic J J Cardiovasc Comput Tomogr; 2015; 9(5):382-92. PubMed ID: 26164109 [TBL] [Abstract][Full Text] [Related]
19. Transfemoral balloon expandable aortic valve implantation on a patient with chronic lymphocytic leukemia following mitral valve prosthesis. Bozkurt E; Sari C; Keles T; Durmaz T; Aslan A; Bastug S; Akar Bayram N; Akcay M; Ayhan H; Kasapkara H; Bilen E Minerva Cardioangiol; 2014 Dec; 62(6):501-4. PubMed ID: 25420504 [No Abstract] [Full Text] [Related]
20. Balloon aortic valvuloplasty as a treatment option in the era of transcatheter aortic valve implantation. Costopoulos C; Sutaria N; Ariff B; Fertleman M; Malik I; Mikhail GW Expert Rev Cardiovasc Ther; 2015 May; 13(5):457-60. PubMed ID: 25865236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]